articleCellApr 29, 2020BRONZE OA

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

TRTimothy R. AbbottGDGirija DhamdhereYLYanxia LiuXLXueqiu LinLGLaine Goudy

Stanford University · DNARx (United States) · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

503
total citations
FWCI
31.51
Percentile
100%
References
56
Citations per year

Authors

15

Topics & keywords

Topics
Keywords
  • CRISPR
  • Biology
  • Virology
  • Virus
  • Coronavirus
  • Pandemic
  • Influenza A virus
  • Coronavirus disease 2019 (COVID-19)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding